Home / Stocks / Zydus Wellness Limited
ZYDUSWELL

Zydus Wellness Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹455.85

Change

-0.75 (-0.16%)

Open

₹456.0

Prev. Close

₹456.6

Day High

₹461.45

Day Low

₹453.0

Volume Analysis

Traded

61,237

Delivered

27,674

Delivery %

45.19%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (1)

  • •Low return on equity (3.98%)

Opportunities (1)

  • •Strong 3-year revenue growth (20.7%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹468.99 ₹465.22 ₹460.54 ₹456.77 ₹452.09 ₹448.32 ₹443.64
Fibonacci ₹465.22 ₹461.99 ₹460.0 ₹456.77 ₹453.54 ₹451.55 ₹448.32
Camarilla ₹458.17 ₹457.4 ₹456.62 ₹456.77 ₹455.08 ₹454.3 ₹453.53

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-1.81%

1 Week

-3.22%

1 Month

-7.35%

3 Months

-7.12%

6 Months

-7.05%

1 Year

-0.07%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹161.08

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

3.27%

Net margin 4.91% × asset turnover 0.38x × equity multiplier 1.75x

Company Overview

Sector

Fast Moving Consumer Goods

Market Cap

₹14,952 Cr

P/E (TTM)

59.5

ROE

3.98%

Book Value

₹186.0

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

Zydus Wellness Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 53/100. The strongest factor is Corporate Governance (88/100), while Valuation (26/100) is the weakest area to weigh before deciding. Notably: Low return on equity (3.98%). Strong 3-year revenue growth (20.7%).

TopFund Score — Fundamentals Quality

53/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

86

Growth

58

Valuation

26

Cash Flow

43

Corporate Governance

88

Momentum

44

Institutional Ownership

46

Business Quality

42

Risk & Volatility

61

Liquidity

31

From Screener.in

  • +Company is expected to give good quarter
  • −Stock is trading at 2.53 times its book value
  • −Company has a low return on equity of 5.09% over last 3 years.
  • −Company might be capitalizing the interest cost
  • −Dividend payout has been low at 14.1% of profits over last 3 years

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Q2 FY27 earnings call transcript shared; sales grew 74.6% to Rs 11,227 million.

Newspaper publication regarding unaudited financial results for the quarter and half year ended September 30, 2026

Audio recording of investor call on Q2 FY27 unaudited results is now available on the website.

Zydus Wellness reports Q2 FY27 net sales up 74.6% to ₹11,227 million; H1 sales up 70.1%.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 440 403 783 841 493 462 913 861 651 965 1,485 1,437 1,127
Expenses + 423 391 620 686 473 447 723 705 628 904 1,215 1,195 1,041
Operating Profit 17 13 162 155 20 15 190 156 23 61 270 242 86
OPM % 3.82% 3.15% 20.73% 18.47% 3.98% 3.2% 20.81% 18.07% 3.54% 6.32% 18.19% 16.82% 7.59%
Other Income + 4 3 4 5 10 4 1 3 -33 -6 1 4 6
Interest 7 6 6 4 1 3 4 3 16 41 39 26 27
Depreciation 6 6 6 5 5 5 13 11 25 56 55 57 57
Profit before tax 9 4 154 152 24 10 173 145 -51 -42 177 162 8
Tax % 31.4% 91.89% 2.66% 2.57% 11.81% 36.63% 0.87% 11.98% 4.35% -3.86% 8.63% 26.65% 32.89%
Net Profit + 6 0 150 148 21 6 172 128 -53 -40 162 119 5
EPS in Rs 0 0 5 5 1 0 5 4 -2 -1 5 4 0
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 3 -3 10 20 12 15 17 2 32 109 63 67 73

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 431 397 431 513 843 1,767 1,867 2,009 2,255 2,328 2,709 3,961 5,013
Expenses + 331 305 331 387 658 1,446 1,522 1,664 1,918 2,020 2,329 3,451 4,355
Operating Profit 100 91 99 125 185 321 344 345 337 308 380 510 658
OPM % 23.0% 23.0% 23.0% 24.0% 22.0% 18.0% 18.0% 17.0% 15.0% 13.0% 14.0% 13.0% 13.0%
Other Income + 28 32 32 35 28 -33 -123 10 -5 0 20 -34 6
Interest 0 0 1 2 30 140 84 26 16 24 12 98 133
Depreciation 8 7 7 9 13 26 25 24 25 24 28 147 225
Profit before tax 120 117 124 150 171 121 112 306 291 260 359 230 306
Tax % 7.0% 10.0% 10.0% 9.0% 0.0% -17.0% -6.0% -1.0% -7.0% -3.0% 3.0% 14.0% —
Net Profit + 111 105 111 137 171 142 119 309 310 267 347 197 246
EPS in Rs 6 5 6 7 6 5 4 10 10 8 11 6 8
Dividend Payout % 22.0% 25.0% 23.0% 23.0% 17.0% 20.0% 27.0% 10.0% 10.0% 12.0% 11.0% 19.0% —
Sales growth 7 -8 9 19 64 110 6 8 12 3 16 46 74

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 367 439 518 652 3,329 3,403 4,504 4,780 5,059 5,294 5,608 5,762 5,844
Borrowings + 0 0 25 25 1,569 1,519 550 387 297 329 188 3,203 3,167
Other Liabilities + 102 89 100 112 503 610 548 461 413 462 582 1,161 1,277
Total Liabilities 508 568 682 829 5,459 5,590 5,666 5,692 5,833 6,148 6,442 10,190 10,352
Fixed Assets + 84 82 103 104 4,567 4,674 4,667 4,710 4,732 4,708 5,125 8,596 8,602
CWIP 0 0 0 0 10 4 4 12 13 10 15 23 18
Investments 0 94 30 148 46 110 0 27 70 78 36 5 223
Other Assets + 423 391 550 577 835 802 995 943 1,018 1,354 1,266 1,566 1,509
Total Assets 508 568 682 829 5,459 5,590 5,666 5,692 5,833 6,148 6,442 10,190 10,352
Equity Capital 39 39 39 39 58 58 64 64 64 64 64 64 64

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 69 90 77 69 149 259 287 237 92 246 380 226
Cash from Investing Activity + 29 -28 -72 -59 -4,092 -17 -10 -59 -85 -178 -207 -2,881
Cash from Financing Activity + -27 -58 -6 -2 4,052 -260 -216 -234 -138 -26 -186 2,698
Net Cash Flow 71 4 -1 8 109 -18 60 -56 -132 43 -13 44
Free Cash Flow 72 86 46 61 132 235 269 162 47 220 315 126
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 80 114 86 64 115 81 83 70 28 81 99 50

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 69.15% → 69.63%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 7.91% 7.71% 7.65% 6.67% 6.89% 7.3% 7.83% 8.18% 8.51% 8.32% 7.92% 7.42%
Promoters 69.15% 69.62% 69.62% 69.62% 69.62% 69.64% 69.64% 69.64% 69.64% 69.64% 69.63% 69.63%
FII 3.25% 3.26% 3.29% 3.36% 3.37% 3.29% 3.25% 3.43% 3.27% 3.17% 3.32% 3.57%
DII 19.67% 19.41% 19.44% 20.37% 20.12% 19.76% 19.27% 18.76% 18.58% 18.87% 19.13% 19.39%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Fast Moving Consumer Goods — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Zydus Wellness Limited (this stock) 14,952 59.5 2.53 3.98%
Lt Foods Limited 14,557 22.2 2.97 14.8%
Balrampur Chini Mills Ltd 13,489 32.2 2.84 9.52%
Honasa Consumer Limited 16,896 59.0 11.36 15.7%
Ccl Products (i) Ltd 12,859 27.9 4.84 18.0%
Tilaknagar Industries Ltd 12,850 62.2 4.25 12.6%
Doms Industries Limited 12,251 60.2 9.57 20.7%

Which Mutual Funds Hold Zydus Wellness Limited?

Frequently Asked Questions about Zydus Wellness Limited

Community Sentiment

What are other investors saying about Zydus Wellness Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.